Aisling Capital announced 4.17 million shares in Zeltiq Aesthetics, Inc. (ZLTQ), corresponding to a 12.7% activist stake. No other hedge fund in our tracking list has ever reported a position in the stock before. ZLTQ was started for trading on October 19th, and was priced at $14.75 immediately after its initial offering of 7 million shares at $13.00 per share. Now the stock is closed at $13.95 on November 2nd.
Aisling Capital is an investment firm specializing in Healthcare advises. The firm focuses on investment funds that invest in products, technologies, and global businesses that advance health. The firm is led by a group of investment professionals with diverse backgrounds in industry, science, and finance. The principals of Aisling Capital is to seek to provide the financing, relationships, and guidance needed to build highly successful companies.
ZELTIQ Aesthetics, Inc. is a medical technology company. It utilizes its proprietary controlled-cooling technology platform to develop and commercialize products. The company markets its products through distributors and dermatologists. The company was formerly known as Juniper Medical, Inc. before July 2007. The company was founded in 2005 and is based in Pleasanton, California.